Clinical Trials Browser

Phase 4 × Breast Neoplasms × Gynecologic × Clear all

NCT05949424 2023-11-29

OPTI-DOSE

Phase 4 Unknown

BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT03384511 2018-02-20

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Phase 4 Completed

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT00613275 2016-06-15

Patient Navigation in the Safety Net:CONNECTeDD

Phase 4 Completed

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

NCT02562170 2015-09-29

Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study

Phase 4 Completed

BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Phase 4 Completed

BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

NCT00190697 2007-05-25

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Phase 4 Completed

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms